RaQualia Pharma Inc
TSE:4579

Watchlist Manager
RaQualia Pharma Inc Logo
RaQualia Pharma Inc
TSE:4579
Watchlist
Price: 1 010 JPY -2.23%
Market Cap: 24.7B JPY

Wall Street
Price Targets

Price Targets Summary
RaQualia Pharma Inc

There are no price targets for RaQualia Pharma Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
RaQualia Pharma Inc Competitors:
Price Targets
2M7C
China Medical System Holdings Ltd
29% Upside
HROW
Harrow Health Inc
47% Upside
GS71
GSK plc
1% Upside
VIRP
Virbac SA
16% Upside
ALM
Almirall SA
10% Upside
GLAND
Gland Pharma Ltd
21% Upside
4528
Ono Pharmaceutical Co Ltd
17% Downside
AGY
Allergy Therapeutics PLC
21% Upside

Revenue
Forecast

Revenue Estimate
RaQualia Pharma Inc

For the last 13 years the compound annual growth rate for RaQualia Pharma Inc's revenue is 12%. The projected CAGR for the next 2 years is 22%.

12%
Past Growth
22%
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Operating Income
Forecast

Operating Income Estimate
RaQualia Pharma Inc

Operating Income forecast
is not available for
RaQualia Pharma Inc

Net Income
Forecast

Net Income Estimate
RaQualia Pharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
45%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RaQualia Pharma Inc's stock price target?
Not Available

RaQualia Pharma Inc doesn't have any price targets made by Wall Street professionals.

What is RaQualia Pharma Inc's Revenue forecast?
Projected CAGR
22%

For the last 13 years the compound annual growth rate for RaQualia Pharma Inc's revenue is 12%. The projected CAGR for the next 2 years is 22%.

Back to Top